These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. High-sensitivity C-reactive protein is not a risk factor for venous thromboembolism: the Tromso study. Hald EM; Brækkan SK; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Hansen JB Haematologica; 2011 Aug; 96(8):1189-94. PubMed ID: 21508123 [TBL] [Abstract][Full Text] [Related]
29. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Cugno M; Marzano AV; Bucciarelli P; Balice Y; Cianchini G; Quaglino P; Calzavara Pinton P; Caproni M; Alaibac M; De Simone C; Patrizi A; Cozzani E; Papini M; Tedeschi A; Berti E; Rosendaal FR; Thromb Haemost; 2016 Jan; 115(1):193-9. PubMed ID: 26245987 [TBL] [Abstract][Full Text] [Related]
30. The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. Bakirci EM; Topcu S; Kalkan K; Tanboga IH; Borekci A; Sevimli S; Acikel M Clin Appl Thromb Hemost; 2015 Mar; 21(2):181-5. PubMed ID: 23814171 [TBL] [Abstract][Full Text] [Related]
31. Protein N-linked homocysteine is associated with recurrence of venous thromboembolism. Szlauer A; Mielimonka A; Głowacki R; Borowczyk K; Stachniuk J; Undas A Thromb Res; 2015 Nov; 136(5):911-6. PubMed ID: 26371408 [TBL] [Abstract][Full Text] [Related]
32. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Holst AG; Jensen G; Prescott E Circulation; 2010 May; 121(17):1896-903. PubMed ID: 20404252 [TBL] [Abstract][Full Text] [Related]
33. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism. Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709 [TBL] [Abstract][Full Text] [Related]
35. Serum levels of 25(OH)D are not associated with venous thromboembolism in the elderly population. A case-control study. Andro M; Delluc A; Moineau MP; Tromeur C; Gouillou M; Lacut K; Carré JL; Gentric A; Le Gal G Thromb Haemost; 2016 Jan; 115(1):169-75. PubMed ID: 26538494 [TBL] [Abstract][Full Text] [Related]
36. Time to Event Analysis for the Development of Venous Thromboembolism After Spinal Fusion ≥ 5 Levels. McClendon J; Smith TR; O'Shaughnessy BA; Sugrue PA; Thompson SE; Koski TR World Neurosurg; 2015 Sep; 84(3):826-33. PubMed ID: 25871780 [TBL] [Abstract][Full Text] [Related]
37. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6. Matos MF; Lourenço DM; Orikaza CM; Gouveia CP; Morelli VM Metab Syndr Relat Disord; 2013 Feb; 11(1):29-34. PubMed ID: 23025692 [TBL] [Abstract][Full Text] [Related]
38. The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism: A Randomized Clinical Trial. Gholami K; Talasaz AH; Entezari-Maleki T; Salarifar M; Hadjibabaie M; Javadi MR; Dousti S; Hamishehkar H; Maleki S Clin Appl Thromb Hemost; 2016 Jul; 22(5):483-9. PubMed ID: 25601896 [TBL] [Abstract][Full Text] [Related]
39. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: A new prospective study and meta-analysis. Kunutsor SK; Kurl S; Zaccardi F; Laukkanen JA Atherosclerosis; 2016 Feb; 245():171-80. PubMed ID: 26724527 [TBL] [Abstract][Full Text] [Related]